Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars

PHASE4CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Irreversible Pulpitis
Interventions
DRUG

IANB Articaine

IANB anesthesia given with 1.7cc of 4% articaine, 1:100,000 epinephrine.

DRUG

SUP Articaine

After unsuccessful IANB with articaine, proceed to give 1.7cc of 4% articaine with 1:100,000 epinephrine in buccal mucosa as a supplemental infiltration injection (SUP).

DRUG

SUP Lidocaine

After unsuccessful IANB with articaine, proceed to give 1.7cc of 2% lidocaine with 1:100,000 epinephrine in buccal mucosa as a supplemental infiltration injection (SUP).

Trial Locations (1)

48109

University of Michigan, School of Dentistry Clinics, Ann Arbor

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Dentsply International

INDUSTRY

lead

University of Michigan

OTHER

NCT01496846 - Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars | Biotech Hunter | Biotech Hunter